This new 249-page report from VPGMarketResearch.com provides a comprehensive analysis of the US therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.
The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid and Vancomycin.
During the next five years, the TDM market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.
2015-2019 US Therapeutic Drug Monitoring (TDM) Market: Hospitals, Commercial Labs, Physician Offices is a unique market and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study provides five-year forecasts for major TDM assays; compares features of leading analyzers; and profiles key competitors.
Contains 249 pages and 19 tables
SIMILAR MARKET STUDIES
2016 POC/Point-of-Care Clinical Chemistry and Immunodiagnostic Testing: Physician Offices, Emergency Rooms, Operating Suites, ICUs/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers-Supplier Shares, Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation Review, Competitive Strategies
November 1999 | $0 | View Details >>
2016-2020 US Transfusion Analyzers and Consumables Market: Molecular Blood Typing, Grouping and Infectious Disease NAT/Nucleic Acid Testing- Supplier Shares, Country Segment Forecasts for over 40 Tests, Strategies, Technologies, Instrumentation
Complete report $9,700. DataPack (test volumes, sales forecasts, supplier shares) $6,300. This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the US molecular blood banking market during the next five years, and assist industry executives in developing effective business, new product ...
March 2016 | $0 | View Details >>
2017 France Molecular Blood Typing, Grouping and Infectious Disease NAT Market: Supplier Shares, Sales Forecasts by Test and Market Segment, Competitive Strategies, Technology Trends, Instrumentation Review
Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950. This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the French molecular blood banking market during the next five years, and assist industry executives in developing effective business, new product ...
March 2017 | $0 | View Details >>
About This ReportThis new 280-page report from VPGMarketResearch.com presents detailed analysis of the German STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test volume and sales projections for Hospitals and Commercial/Private Labs.In addition to ...
July 2015 | $1250 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research